Zynerba Pharmaceuticals, Inc. (ZYNE) Social Stream
Zynerba Pharmaceuticals Inc (ZYNE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Zynerba Pharmaceuticals Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ZYNE's average price target has moved down $0.48 over the prior 35 weeks.
Over the past 47 weeks, ZYNE's average upside potential has been 74.82%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ZYNE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ZYNE as an investment opportunity.
- In the context of all US stocks, Zynerba Pharmaceuticals Inc's average analyst price target is higher than 17.86% of them.
- In the context of all US stocks, Zynerba Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 264.83% of them.
- Zynerba Pharmaceuticals Inc's number of analysts covering the stock is greater than 258.26% of stocks in the micro market cap category.
- In the context of stocks in the micro market cap category, Zynerba Pharmaceuticals Inc's variance in analysts' estimates is lower than -152.51% of them.
What is the outlook for ZYNE? Use POWR Ratings for clearer insight into price direction.